L & S Advisors Inc Alnylam Pharmaceuticals, Inc. Transaction History

L & S Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$120.42 - $169.29 $1.12 Million - $1.58 Million	9,330 New	9,330 $1.36 Million
Q3 2020 Nov 13, 2020	SELL	$121.19 - $165.49 $575,652 - $786,077	-4,750 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$104.21 - $156.44 $251,041 - $376,863	2,409 Added 102.9%	4,750 $704,000
Q1 2020 May 13, 2020	SELL	$93.12 - $133.99 $270,234 - $388,838	-2,902 Reduced 55.35%	2,341 $255,000
Q4 2019 Feb 13, 2020	BUY	$74.51 - $124.23 $390,655 - $651,337	5,243 New	5,243 $604,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on L & S Advisors Inc with notifications on news.